SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hrenko George

(Last)

(First)

(Middle)

1000 CEDAR HOLLOW ROAD

SUITE 102

(Street)

MALVERN

19355

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BioTelemetry, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP - Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/27/2017		M		2,654	A	$10.36	23,172	D
Common Stock	02/27/2017		S⁽¹⁾		2,654	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		4,876	A	$10.36	25,394	D
Common Stock	02/27/2017		S⁽¹⁾		4,876	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		416	A	$8.68	20,934	D
Common Stock	02/27/2017		S⁽¹⁾		416	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		9,211	A	$8.68	29,729	D
Common Stock	02/27/2017		S⁽¹⁾		9,211	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		822	A	$2.54	21,340	D
Common Stock	02/27/2017		S⁽¹⁾		822	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		24,639	A	$2.54	45,157	D
Common Stock	02/27/2017		S⁽¹⁾		24,639	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		38,495	A	$2.8	59,013	D
Common Stock	02/27/2017		S⁽¹⁾		38,495	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		15,000	A	$4.67	35,518	D
Common Stock	02/27/2017		S⁽¹⁾		15,000	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		12,953	A	$4.67	33,471	D
Common Stock	02/27/2017		S⁽¹⁾		12,953	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		4,077	A	$8.79	24,595	D
Common Stock	02/27/2017		S⁽¹⁾		4,077	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		7,500	A	$6.95	28,018	D
Common Stock	02/27/2017		S⁽¹⁾		7,500	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		2,500	A	$6.95	23,018	D
Common Stock	02/27/2017		S⁽¹⁾		2,500	D	$25.95⁽²⁾	20,518	D
Common Stock	02/27/2017		M		2,900	A	$23.58	23,418	D
Common Stock	02/27/2017		S⁽¹⁾		2,900	D	$25.95⁽²⁾	20,518	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options	$23.58	02/27/2017		M			2,900	12/15/2009	03/04/2019	Common Stock	2,900	$0.00	0	D
Stock Options	$6.95	02/27/2017		M			2,500	08/12/2013	08/12/2019	Common Stock	2,500	$0.00	0	D
Stock Options	$6.95	02/27/2017		M			7,500	08/12/2010	08/12/2019	Common Stock	7,500	$0.00	0	D
Stock Options	$8.79	02/27/2017		M			4,077	12/31/2010	05/10/2020	Common Stock	4,077	$0.00	0	D
Stock Options	$4.67	02/27/2017		M			12,953	12/31/2011	03/04/2021	Common Stock	12,953	$0.00	0	D
Stock Options	$4.67	02/27/2017		M			15,000	03/11/2012	03/04/2021	Common Stock	4.67	$0.00	0	D
Stock Options	$2.8	02/27/2017		M			38,495	12/31/2012	02/21/2022	Common Stock	38,495	$0.00	0	D
Stock Options	$2.54	02/27/2017		M			24,639	12/31/2013	02/19/2023	Common Stock	24,693	$0.00	0	D
Stock Options	$2.54	02/27/2017		M			822	12/31/2013	02/19/2023	Common Stock	822	$0.00	0	D
Stock Options	$8.68	02/27/2017		M			9,211	12/31/2014	02/14/2024	Common Stock	9,211	$0.00	0	D
Stock Options	$8.68	02/27/2017		M			416	12/31/2014	02/14/2024	Common Stock	416	$0.00	0	D
Stock Options	$10.36	02/27/2017		M			4,876	12/31/2014	02/16/2025	Common Stock	4,876	$0.00	0	D
Stock Options	$10.36	02/27/2017		M			2,654	12/31/2015	02/16/2025	Common Stock	2,654	$0.00	0	D

Explanation of Responses:

1. Represents sales pursuant to the reporting person's retirement.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.60 to $26.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this Form 4.

Remarks:

	/s/ Jason D. Herpel, by power of attorney	03/01/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.